Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

267 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 267 results

Early research (Phase 1)WithdrawnNCT03131700
What this trial is testing

Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator

Who this might be right for
Healthy
TRPHARM
Large-scale testing (Phase 3)Study completedNCT03976102
What this trial is testing

Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Dr. Reddy's Laboratories Limited 317
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Large-scale testing (Phase 3)Study completedNCT01895309
What this trial is testing

A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Samsung Bioepis Co., Ltd. 596
Testing effectiveness (Phase 2)WithdrawnNCT03766607
What this trial is testing

Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Korean South West Oncology Group
Early research (Phase 1)Study completedNCT04798326
What this trial is testing

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults

Who this might be right for
Bone Tumor
Mabwell (Shanghai) Bioscience Co., Ltd. 120
Not applicableUnknownNCT05424393
What this trial is testing

Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients

Who this might be right for
Rheumatoid Arthritis
The First Affiliated Hospital of Xiamen University 500
Early research (Phase 1)Study completedNCT03919448
What this trial is testing

A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 112
Not applicableStudy completedNCT03885037
What this trial is testing

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Who this might be right for
Rheumatoid Arthritis
Pfizer 77
Post-approval studies (Phase 4)Ended earlyNCT04131322
What this trial is testing

Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.

Who this might be right for
Crohn DiseaseUlcerative Colitis
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 24
Early research (Phase 1)Study completedNCT04439929
What this trial is testing

Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects

Who this might be right for
Healthy Participants
Turgut İlaçları A.Ş. 168
Large-scale testing (Phase 3)Active Not RecruitingNCT05346224
What this trial is testing

Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHER2-positive Breast Cancer
Shanghai Henlius Biotech 900
Not applicableUnknownNCT05530785
What this trial is testing

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Yongchang Zhang 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07501052
What this trial is testing

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Who this might be right for
Neovascular (Wet) Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema+1 more
Sam Chun Dang Pharm. Co. Ltd. 33
Large-scale testing (Phase 3)Study completedNCT05087030
What this trial is testing

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Gedeon Richter Plc. 473
Large-scale testing (Phase 3)Looking for participantsNCT06847724
What this trial is testing

Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Sandoz 175
Not applicableStudy completedNCT05424926
What this trial is testing

Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis
Assistance Publique - Hôpitaux de Paris 22
Not applicableStudy completedNCT02922192
What this trial is testing

Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis

Who this might be right for
Rheumatoid ArthritisInflammatory Bowel DiseasePsoriasis+2 more
Biologics & Biosimilars Collective Intelligence Consortium 90,360
Not applicableUnknownNCT04422171
What this trial is testing

A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar

Who this might be right for
IBD Patients, Originator Treatment, Biosimilar, Switch Back
University Hospital, Grenoble 400
Load More Results